Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists

Details for Australian Patent Application No. 2008221194 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Colucci, John; Boyd, Michael; Han, Yongxin

Agent Spruson & Ferguson

Pub. Number AU-A-2008221194

PCT Pub. Number WO2008/104055

Priority 60/903,494 26.02.07 US

Filing date 22 February 2008

Wipo publication date 4 September 2008

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/104055 Priority application(s): WO2008/104055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008221197-Gasification system with processed feedstock/Char conversion and gas reformulation

2008221187-Method and system for removing manganese from waste liquors